Jean-Frederic Viret, Chief Financial Officer at Coherus BioSciences, Inc. (CHRS), sold 740 shares at $21.78 ($16K) on 2019-09-23, disclosed to the SEC on 2019-09-25.
Scheduled sale ($16k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CHRS | SELL | 2020-11-19 | $35K | — | Filing → |
| CHRS | SELL | 2020-10-16 | $117K | — | Filing → |
| CHRS | SELL | 2020-05-22 | $23K | — | Filing → |